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Anaplastic large cell lymphoma (ALCL), first described as Ki-1 (CD30)-positive large cell lymphoma, has been recognized as a clinicopathologic entity (1). ALCL was originally described by Stein et al. (2) as a neoplasm composed of large pleomorphic lymphoid cells that express the CD30 antigen and have a propensity to involve lymph node sinuses. Although most of these lymphomas were of T/null lineage, some cases were of B-cell lineage. More recent, it has been recognized that ALCL can exhibit a broad spectrum of cytologic features (3) . Furthermore, a subset of ALCL overexpresses anaplastic lymphoma kinase (ALK)-1 as a result of a characteristic cytogenetic abnormality, t(2;5)(p23; q35), and is associated with young patient age and better prognosis (4, 5) . In contrast to ALCL of T/null lineage, most CD30-positive large B-cell lymphomas do not carry the t(2;5)(p23;q35), are negative for ALK-1, and clinically behave worse than ALCL and more similar to diffuse large B-cell lymphomas (6, 7) . Thus, CD30-positive large B-cell lymphoma has been excluded from the ALCL category in the revised European-American classification of lymphoid neoplasm and the recently proposed World Health Organization classification systems (6, 8) .
Diffuse large B-cell lymphoma can selectively and predominantly infiltrate lymph node sinuses; this pattern has been recognized as an unusual morphologic variant of this entity (9) . Probably related to its rarity, it has not been well characterized. A subset of sinusoidal large B-cell lymphomas are the so-called "microvillous lymphomas," but these neoplasms are uniformly negative for CD30 (10, 11) . Sinusoidal large B-cell lymphomas with CD30 expression are even more rare. To our knowledge, only three such cases were briefly described in one recent report; all three patients had a history of follicular lymphoma before transformation to CD30-positive large B-cell lymphoma (12) . We collected 11 cases of CD30-positive, sinusoidal large B-cell lymphomas in patients without a previous history of lymphoma, and the clinical, morphologic, and immunophenotypic features of these cases are presented.
MATERIALS AND METHODS

Case Selection
All 11 cases were found and collected from the files of the Department of Laboratory Medicine and Pathology at the Cross Cancer Institute. We initially searched our files from 1989 to 1999 for a diagnosis of diffuse large B-cell lymphoma with immunohistochemical results of CD30 expression. All cases of diffuse large B-cell lymphoma with CD30 positivity were reviewed, and cases were selected on the basis of the following criteria: 1) diffuse large cell lymphoma; 2) B-cell lineage, as established by CD20 and/or CD79a expression by immunohistochemistry; 3) evidence of a sinusoidal growth pattern; and 4) by immunohistochemistry, more than 50% of tumor cells showing expression of the CD30 antigen in the evenly stained areas. Hematoxylin-eosin stains were performed on formalin-fixed, paraffinembedded tissue sections.
Immunohistochemistry
Monoclonal antibodies specific for the following antigens were used: CD3, 1:50 (Novocastra Laboratories, Newcastle upon Tyne, UK); CD15 (LeuM1), 1:5 (Becton Dickinson, San Jose, CA); CD20 (L26), 1:100; CD30 (BerH2), 1:5; CD45 (2D1), 1:20; CD79a, 1:5; EMA (E29), 1:20; and ALK-1, 1:25 (DAKO, Mississauga, Ontario, Canada).
Tissue sections were mounted onto precleaned slides (Superfrost; Fisher Scientific, Pittsburgh, PA), baked at 56°C for 60 min, deparaffinized with xylene, and rehydrated with ethanol to distilled water. A prestaining heat-induced antigen retrieval method was used, as previously described (13) . Briefly, tissue sections were placed in sodium citrate buffer (0.01 mol/L, pH 6.0) and heated in a microwave oven for 10 min. An automated immunostainer (Ventana Biotek Medical Systems, Tucson, AZ) was used. Reactivity was detected by an avidin-biotin immunoperoxidase method with 3,3Ј-diaminobenzidine-tetrahydrochloride dihydrate (Ventana Biotek Medical System) as the chromogen.
In Situ Epstein-Barr Virus Hybridization
In situ hybridization studies to detect EpsteinBarr virus (EBV) RNA were performed using a 30-base oligonucleotide complementary to a portion of EBER1 genome that is actively transcribed (up to 10 7 copies per cell) in latently infected cells. The methods have been detailed elsewhere (14) .
RESULTS
Clinical Data
A total of 11 cases were identified. The clinical data of these 11 patients are summarized in Table 1 . With the exception of one consultation case (Patient 4), all patients were treated and followed up at the Cross Cancer Institute. There were five men and 6 women, who ranged in age from 36 to 82 years (mean, 63.2 years). Excluding Patient 4, for whom detailed clinical data were not available, all patients presented with primary nodal disease, and all of them were treated with a curative intent, receiving standard combination chemotherapy including CHOP (cyclophosphamide, hydroxydaunomycin, Oncovin, and prednisone) with or without localized radiotherapy. One patient (Patient 8) also had an autologous bone marrow transplantation after relapse. Overall, 6 of 10 patients died of disease (mean survival, 12.7 months). Of the remaining four patients, one (Patient 8) had relapse within 1 year, which necessitated bone marrow transplantation. Three were alive without evidence of disease, although two of these three patients were recently diagnosed, with the follow-up time period being 11 months and 14 months, respectively. Other than Patient 4, whose HIV status was unknown, all of the other patients had no known risk factors for HIV infection. In addition, none of these patients had a previous history of lymphoma.
Histologic Findings
All 11 cases were originally diagnosed as diffuse large cell lymphoma involving lymph nodes. All cases had evidence of a sinusoidal growth pattern, often associated with residual atrophic lymphoid follicles (Fig. 1) . A subset (4 of 11) contained foci of confluent tumor cell growth. Focally, the tumor cells showed apparent cohesiveness. All cases contained large pleomorphic lymphoid cells with polylobulated nuclei, vesicular chromatin, prominent nucleoli, and abundant amphophilic cytoplasm (Fig. 2) , although some cases (3 of 11) also contained a population of monomorphic large lymphoid cells (Fig. 3) . Scattered Reed-Sternberg-like cells were also seen in some cases. Necrosis and admixed neutrophils were the other more common findings. Notably, tumor cells with an eosinophilic paranuclear region were absent.
Immunohistochemical Findings
The results of the immunohistochemical studies are summarized in Table 2 . All cases were positive for CD20 and/or CD79a (Fig. 4a) and negative for CD3, confirming their B-cell lineage. Each neoplasm was also positive for CD45 and CD30 (Fig.  4b) . None of eight cases tested was positive for ALK-1. One of six cases assessed was positive for EMA. 
In Situ EBV Studies
Two of these 11 cases (Patients 4 and 10) were positive for EBV by in situ hybridization. The HIV status of Patient 4 (consultation case) was unknown, and a positive signal was detected in 30 to 40% of the tumor cells (Fig. 5) . The other positive case (Patient 10) was from an 82-year-old man with no known risk factors for HIV infection; a positive signal was detected in roughly 10% of the tumor cells.
DISCUSSION
We describe 11 cases of a highly unusual variant of nodal diffuse large B-cell lymphoma, characterized by the coexistence of a sinusoidal infiltrative pattern and CD30 expression. Although sinusoidal large B-cell lymphomas have been described (9) and CD30 expression in a subset of diffuse large B-cell lymphoma is widely recognized, only three cases of CD30-positive large B-cell lymphoma that also had a sinusoidal pattern have been described; all had a history of follicular lymphoma (12) . In contrast to these three previously reported cases, all of the cases described here were from patients without a previous history of lymphoma.
Most cases (8 of 11) were composed predominantly of cells with cytologic features similar to those seen in the classic type of anaplastic large cell lymphoma. The cytologic features, cohesiveness of the tumor cells, and the sinusoidal growth pattern are suggestive of metastatic carcinoma and melanoma, which can be excluded by the appropriate immunohistochemical studies. The overall morphologic features and the CD30 positivity also make these lesions a close mimic of ALCL. However, despite the overall histologic similarities with ALCL, neoplastic cells with an eosinophilic paranuclear region, which have been reported as a constant finding for ALK-positive ALCL (3), were absent. These tumors can be further distinguished from ALCL by virtue of their B-cell lineage, uniform CD45 expression, infrequent EMA positivity, and the absence of ALK-1 expression.
In addition to ALCL and metastatic melanoma/ carcinoma, the other entities that should be included in the differential diagnosis are microvillous lymphoma and the recently described diffuse large cell lymphomas that express ALK but without t(2;5) or CD30 expression. Despite the close morphologic similarities, microvillous lymphomas are uniformly 
TABLE 2. Immunohistochemical and In Situ EBV Studies
Patient CD3 CD20 CD79a CD30 ALK-1 EMA CD45 EBV In Situ CD30 negative (10) . Similar to our cases, the subtype of diffuse large B-cell lymphomas described by Delsol et al. (15) generally have a sinusoidal pattern. However, they are composed of monomorphic immunoblasts, and they differ immunophenotypically from our cases, being uniformly CD30 negative, EMA positive, and ALK positive.
Clinically, sinusoidal CD30-positive large B-cell lymphomas seem to be largely a disease of older individuals. In our series, the mean age was 63.2 years and 9 of 11 patients were older than 55 years. The male-to-female ratio was 1:1.2. These data are similar to those of standard diffuse large cell lymphomas (mean age, 57 years; male-to-female ratio, 1:1) (9). Despite treatment, most (6 of 10) died of the disease with a relatively short mean survival (12.7 months). In addition, one of the remaining four patients relapsed 6 months after the diagnosis. Thus, these tumors are associated with a worse clinical outcome than that with diffuse large B-cell lymphoma as a group, which has been reported to have a remission rate of 80% and an overall survival rate of 60% (16) . It is interesting that the three cases of CD30-positive sinusoidal large B-cell lymphoma described by Alsabeh et al. (12) also did poorly: one patient died 10 months after diagnosis, and two patients had relapse of the disease shortly after bone marrow transplantation. Although it has been shown that CD30 expression in diffuse large B-cell lymphoma does not have any significant impact on survival (7), large B-cell lymphoma with CD30 positivity and a sinusoidal growth pattern may in fact carry a poor prognosis.
We found evidence of EBV infection in 2 of these 11 cases by in situ hybridization. EBV also has been demonstrated in some cases of ALCL (17) . It is possible that EBV may play a role in contributing to the pathogenesis of some of these neoplasms. EBV also may be related to the CD30 expression observed in these tumors, because some EBV-related immunoblastic proliferations are known to express CD30 (18) .
CONCLUSION
We presented 11 cases of CD30-positive sinusoidal large B-cell lymphoma, which can closely mimic ALCL. Despite the morphologic and immunophenotypic similarities, they can be distinguished from ALCL by virtue of their B-cell lineage, lack of ALK-1 expression, and lack of cells with an eosinophilic paranuclear region. As a group, they seem to behave aggressively and may be worse than standard diffuse large B-cell lymphomas. Although the biologic nature of these neoplasms is yet to be defined, EBV may play a role in the pathogenesis of some of these neoplasms.
